Does ERENUMAB-AOOE Cause Psychomotor hyperactivity? 7 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Psychomotor hyperactivity have been filed in association with ERENUMAB-AOOE. This represents 0.0% of all adverse event reports for ERENUMAB-AOOE.
7
Reports of Psychomotor hyperactivity with ERENUMAB-AOOE
0.0%
of all ERENUMAB-AOOE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From ERENUMAB-AOOE?
Of the 7 reports.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ERENUMAB-AOOE Cause?
Accidental exposure to product (9,923)
Device difficult to use (9,530)
Wrong technique in product usage process (9,359)
Drug dose omission by device (6,340)
Migraine (4,290)
Drug ineffective (3,813)
Constipation (3,104)
Product storage error (2,958)
Headache (2,787)
Injection site pain (2,715)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which ERENUMAB-AOOE Alternatives Have Lower Psychomotor hyperactivity Risk?
ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE
ERENUMAB-AOOE vs ERGOCALCIFEROL
ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL
ERENUMAB-AOOE vs ERIBULIN
ERENUMAB-AOOE vs ERLOTINIB